Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript [Seeking Alpha]
Aytu BioPharma, Inc. (AYTU)
NASDAQ:AMEX Investor Relations:
aytubio.com/investors/stock-information
Company Research
Source: Seeking Alpha
Joshua Disbrow - CEO & Director Gerwin Westfield - Senior Vice President of Scientific Affairs Ryan J. Selhorn - CFO, Corporate Secretary & Treasurer Greg Pyszczymuka - Chief Commercial Officer Conference Call Participants Stephen M. Stahl Anita Clayton Christoph Correll Nelson Cox - Lake Street Capital Markets, LLC, Research Division Alex Silverman - AWM Investment Company Inc Vishal Mishra - Bard Associates Inc. Conversation Joshua Disbrow CEO & Director I'm Josh Disbrow Co-Founder and Chief Executive Officer of Aytu. And it's my pleasure to welcome you to Aytu Biopharma's first ever Investor Day. Welcome to all those here joining us in-person in New York City, and welcome also to all of those joining via the webcast, great to have you all here. It's an exciting day for Aytu having just announced the formal and official launch of Exxua just this morning prior to the market open, really a thrilling time in the company's history as we look at this transfor
Show less
Read more
Impact Snapshot
Event Time:
AYTU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AYTU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AYTU alerts
High impacting Aytu BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics
AYTU
News
- Earnings To Watch: Aytu BioPharma Inc (AYTU) Reports Q2 2026 Result [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026 [Yahoo! Finance]Yahoo! Finance
- Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.50 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Aytu BioPharma (NASDAQ:AYTU) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... [Yahoo! Finance]Yahoo! Finance
AYTU
Analyst Actions
- 12/10/25 - Ascendiant Capital
AYTU
Sec Filings
- 1/20/26 - Form 8-K
- 12/10/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- AYTU's page on the SEC website